Risk factors | Risk of malignancy |
---|---|
Male: 2 - 3 times increased risk. | |
Less than 20: Risk of malignancy doubled. Above age 45: Increased risk of malignancy. Above 70: Risk of malignancy quadrupled. | |
Latency period is usually 10 - 15 years and mostly occurs 20 - 30 years after exposure. | |
 | There is a 40% absolute risk of malignancy for a thyroid nodule in a patient with previous radiation exposure [9]. |
 | Low dose: 100 times increase risk of malignancy (lifetime risk). |
 | High dose: 300 times increase risk of malignancy (lifetime risk). |
Family history [3] | Presence of thyroid cancer in family members increases risk of malignancy. |
The larger the tumour size, especially when >4 cm, or the presence of obstructive symptoms indicates higher risk of malignancy. | |
History of rapid growth in a few weeks indicates higher risk of malignancy. | |
Hoarse voice or vocal cord palsy with recurrent laryngeal nerve involvement [11] | Presence of hoarse voice or vocal cord palsy indicates high risk of malignancy. |
Cervical lymphadenopathy [11] | Presence of cervical lymphadenopathy indicates high risk of malignancy. |
Characteristics of thyroid swelling [11] | Firm/hard consistency or fixed swelling indicates high risk of malignancy. Soft, mobile or cystic swelling indicates low risk of malignancy. |